COMBINATION THERAPY USING GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONIST COMPOUNDS AND GLP-1 RECEPTOR AGONIST COMPOUNDS

Anti-inflammatory pharmaceutical composition comprising benzopyranyl tetracycles

Dihydropyridazine-3,5-dione derivative and pharmaceuticals containing the same

Antiviral compounds and uses thereof

Antiviral compounds and uses thereof

2-Substituted and 4-substituted aryl nitrone compounds

Inhibition of Glycogen Synthase Kinase and Methods of Treating Autoimmune or Immune Inflammatory Disease

INHIBITORS OF FATTY ACID AMIDE HYDROLASE

1-HETEROCYCLYLALKYL-3-SULFONYLAZAINDOLE OR -AZAINDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS

Substituted AZA-indoles as inhibitors of poly(ADP-ribose) polymerase (PARP)

AEROGEL-BASED ENCLOSURE SYSTEMS

Formulation comprising a drug of low water solubility and method of use thereof

Fused-ring compounds and use thereof as drugs

Method for the treatment of noise phobia in companion animals

Antagonist and agonist which bind to a strong binding site of chemokine receptor

Treatment of neuropathic pain with 6-pyrrolo[3,4-]pyridazine compounds

Pyrrolo[1,2b]pyridazine compounds and their uses

Anti-tumor compounds

1-Heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands

Use of hyaluronic acid or its derivatives to enhance delivery of antineoplastic agents

Inhibitors of fatty acid amide hydrolase

2-Substituted and 4-substituted aryl nitrone compounds

Compounds and methods for the treatment of pain

Compound and method for the treatment of pain

Compounds useful as motilin agonists and method

Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists

Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP)